Picture of Biosergen AB logo

BIOSGN Biosergen AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Development, License Deal For BSG005

Sept 25 (Reuters) - Biosergen AB  BIOSGN.ST :
    * BIOSERGEN AND ALKEM LABORATORIES LTD COLLABORATES TO DEVELOP ANTI-INFECTIVE FOR SEVERE
FUNGAL
INFECTIONS
    * SIGNING OF A CO-DEVELOPMENT AND LICENSE AGREEMENT FOR BSG005, AN INNOVATIVE POLYENE
MACROLIDE,
THROUGH PHASE II AND PHASE III TRIALS FOR SALE IN INDIAN MARKET

Source text for Eikon:  ID:nWkr8VV3kr 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Biosergen AB

See all news